II. Precautions
III. Indications
IV. Contraindications
V. Mechanism
-
Sofosbuvir is a NS5B Polymerase Inhibitor (...buvirs)
- Blocks RNA Polymerase, resulting in inhibition of viral replication
- Leipasvir is a NS5A Protein Inhibitor (...asvirs)
VI. Dosing
VII. Evaluation
- See Hepatitis C Antiviral Regimen for Pre and post-treatment protocols
VIII. Adverse Effects
IX. Drug Interactions
- See Hepatitis C Antiviral Regimen
- No significant CYP450 interactions
-
Sofosbuvir (Sovaldi) Drug Interactions
- See Sofosbuvir
- Avoid potent P-Glycoprotein Inducers (reduce Sofosbuvir efficacy)
- Avoid Amiodarone (severe Bradycardia risk)
-
Antacids (reduce Harvoni absorption)
- Aluminum and Magnesium Salt Antacid or Calcium Carbonate
- H2 Blockers
- May take at the same time as Harvoni, or separated by at least 12 hours
- Do not use equivalent greater than Famotidine 40 mg orally twice daily
- Proton Pump Inhibitors
- May take at the same time as Harvoni on an empty Stomach
- Do not use equivalent greater than Omeprazole 20 mg orally daily
-
Rosuvastatin
- Avoid with Sofosbuvir
- Stribild (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir)
- Avoid with Sofosbuvir
-
Digoxin
- Sofosbuvir may increase Digoxin Levels
X. Monitoring
XI. Efficacy
- As effective as combinations that include Ribavirin and Interferon in Genotype I Hepatitis C infections
XII. Resources
XIII. References
- (2023) Presc Lett, Hepatitis C Treatment Overview, Resource #390902